National Institute on Drug Abuse; Notice of Closed Meetings, 18735 [E9-9255]

Download as PDF Federal Register / Vol. 74, No. 78 / Friday, April 24, 2009 / Notices Since this meeting will be held in a Federal Government Building, the Hubert H. Humphrey Building, Federal security measures are applicable. In planning your arrival time, we recommend allowing additional time to clear security. To gain access to the building, participants will be required to show a government-issued photo identification (for example, driver’s license, or passport), and must be listed on an approved security list before persons are permitted entrance. Persons not registered in advance will not be permitted into the Hubert H. Humphrey Building and will not be permitted to attend the Council meeting. All persons entering the building must pass through a metal detector. In addition, all items brought to the Hubert H. Humphrey Building, whether personal or for the purpose of presentation, are subject to inspection. We cannot assume responsibility for coordinating the receipt, transfer, transport, storage, set-up, safety, or timely arrival of any personal belongings or items used for the purpose of presentation. Individuals requiring sign language interpretation or other special accommodations must contact the DFO via the contact information specified in the FOR FURTHER INFORMATION CONTACT section of this notice by the date listed in the DATES section of this notice. Authority: (Section 1868 of the Social Security Act (42 U.S.C. 1395ee) and section 10(a) of Pub. L. 92–463 (5 U.S.C. App. 2, section 10(a)).) Dated: April 16, 2009. Charlene Frizzera, Acting Administrator, Centers for Medicare & Medicaid Services. [FR Doc. E9–9419 Filed 4–23–09; 8:45 am] BILLING CODE 4120–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health mstockstill on PROD1PC66 with NOTICES National Institute on Drug Abuse; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C. as amended. The contract proposals and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning VerDate Nov<24>2008 16:20 Apr 23, 2009 Jkt 217001 individuals associated with the contract proposals, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute on Drug Abuse Special Emphasis Panel N44DA– 9–2214: Web-based Training for Primary Care Physicians on SBIRT. Time: May 5, 2009. Time: 9:30 a.m. to 1 p.m. Agenda: To review and evaluate contract proposals. Place: The Dupont Hotel, 1500 New Hampshire Avenue, NW., Washington, DC 20036. Contact Person: Nadine Rogers, Ph.D., Scientific Review Administrator, Office of Extramural Affairs, National Institute on Drug Abuse, NIH, DHHS, Room 220, MSC 8401, 6101 Executive Boulevard, Bethesda, MD 20892–8401. 301–402–2105. rogersn2@nida.nih.gov. This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle. Name of Committee: National Institute on Drug Abuse Special Emphasis Panel N44DA– 9–2215: Just Ask: Web-Based Training for SBIRT. Date: May 5, 2009. Time: 10:30 a.m. to 11:30 a.m. Agenda: To review and evaluate contract proposals. Place: The Dupont Hotel, 1500 New Hampshire Avenue, NW., Washington, DC 20036. Contact Person: Nadine Rogers, Ph.D., Scientific Review Administrator, Office of Extramural Affairs, National Institute on Drug Abuse, NIH, DHHS, Room 220, MSC 8401, 6101 Executive Boulevard, Bethesda, MD 20892–8401. 301–402–2105. rogersn2@nida.nih.gov. This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle. Name of Committee: National Institute on Drug Abuse Special Emphasis Panel N44DA– 9–2216–Web-Based Skills Training Agents (topic 91). Date: May 5, 2009. Time: 12:30 p.m. to 1:30 p.m. Agenda: To review and evaluate contract proposals. Place: The Dupont Hotel, 1500 New Hampshire Avenue, NW., Washington, DC 20036. Contact Person: Nadine Rogers, Ph.D., Scientific Review Administrator, Office of Extramural Affairs, National Institute on Drug Abuse, NIH, DHHS, Room 220, MSC 8401, 6101 Executive Boulevard, Bethesda, MD 20892–8401. 301–402–2105. rogersn2@nida.nih.gov. This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle. Name of Committee: National Institute on Drug Abuse Special Emphasis Panel In Vitro Metabolism and Metabolite Quantification (09–8891). PO 00000 Frm 00053 Fmt 4703 Sfmt 4703 18735 Date: May 19, 2009. Time: 9 a.m. to 2 p.m. Agenda: To review and evaluate contract proposals. Place: Courtyard by Marriott Rockville, 2500 Research Boulevard, Rockville, MD 20850. Contact Person: Lyle Furr, Contract Review Specialist, Office of Extramural Affairs, National Institute on Drug Abuse, NIH, DHHS, Room 220, MSC 8401, 6101 Executive Boulevard, Bethesda, MD 20892–8401. (301) 435–1439. lf33c.nih.gov. Name of Committee: National Institute on Drug Abuse Special Emphasis Panel N01DA– 9–2217: Data and Statistics Center for the CTN. Date: May 27–28, 2009. Time: 9:30 a.m. to 4 p.m. Agenda: To review and evaluate contract proposals. Place: Doubletree Bethesda Hotel, 8120 Wisconsin Avenue, Bethesda, MD 20814. Contact Person: Minna Liang, Ph.D., Scientific Review Officer, Training and Special Projects Review Branch, Office of Extramural Affairs, National Institute on Drug Abuse, NIH, 6101 Executive Blvd., Room 220, MSC 8401, Bethesda, MD 20852. 301–435–1432. liangm@nida.nih.gov. Name of Committee: National Institute on Drug Abuse Special Emphasis Panel Communication Support (09–1139). Date: May 28–29, 2009. Time: 9 a.m. to 1 p.m. Agenda: To review and evaluate contract proposals. Place: Courtyard by Marriott Rockville, 2500 Research Boulevard, Rockville, MD 20850. Contact Person: Lyle Furr, Contract Review Specialist, Office of Extramural Affairs, National Institute on Drug Abuse, NIH, DHHS, Room 220, MSC 8401, 6101 Executive Boulevard, Bethesda, MD 20892–8401. (301) 435–1439. lf33c.nih.gov. Name of Committee: National Institute on Drug Abuse Special Emphasis Panel Drug Testing for Clinical Trials (09–8882). Date: June 3, 2009. Time: 9 a.m. to 1 p.m. Agenda: To review and evaluate contract proposals. Place: Courtyard by Marriott Rockville, 2500 Research Boulevard, Rockville, MD 20850. Contact Person: Lyle Furr, Contract Review Specialist, Office of Extramural Affairs, National Institute on Drug Abuse, NIH, DHHS, Room 220, MSC 8401, 6101 Executive Boulevard, Bethesda, MD 20892–8401. (301) 435–1439. lf33c.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos 93279, Drug Abuse and Addiction Research Programs, National Institutes of Health, HHS) Dated: April 16, 2009. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. E9–9255 Filed 4–23–09; 8:45 am] BILLING CODE 4140–01–M E:\FR\FM\24APN1.SGM 24APN1

Agencies

[Federal Register Volume 74, Number 78 (Friday, April 24, 2009)]
[Notices]
[Page 18735]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-9255]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute on Drug Abuse; Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of the following 
meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C. as amended. The contract proposals and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the contract proposals, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute on Drug Abuse Special 
Emphasis Panel N44DA-9-2214: Web-based Training for Primary Care 
Physicians on SBIRT.
    Time: May 5, 2009.
    Time: 9:30 a.m. to 1 p.m.
    Agenda: To review and evaluate contract proposals.
    Place: The Dupont Hotel, 1500 New Hampshire Avenue, NW., 
Washington, DC 20036.
    Contact Person: Nadine Rogers, Ph.D., Scientific Review 
Administrator, Office of Extramural Affairs, National Institute on 
Drug Abuse, NIH, DHHS, Room 220, MSC 8401, 6101 Executive Boulevard, 
Bethesda, MD 20892-8401. 301-402-2105. rogersn2@nida.nih.gov.

    This notice is being published less than 15 days prior to the 
meeting due to the timing limitations imposed by the review and 
funding cycle.

    Name of Committee: National Institute on Drug Abuse Special 
Emphasis Panel N44DA-9-2215: Just Ask: Web-Based Training for SBIRT.
    Date: May 5, 2009.
    Time: 10:30 a.m. to 11:30 a.m.
    Agenda: To review and evaluate contract proposals.
    Place: The Dupont Hotel, 1500 New Hampshire Avenue, NW., 
Washington, DC 20036.
    Contact Person: Nadine Rogers, Ph.D., Scientific Review 
Administrator, Office of Extramural Affairs, National Institute on 
Drug Abuse, NIH, DHHS, Room 220, MSC 8401, 6101 Executive Boulevard, 
Bethesda, MD 20892-8401. 301-402-2105. rogersn2@nida.nih.gov.

    This notice is being published less than 15 days prior to the 
meeting due to the timing limitations imposed by the review and 
funding cycle.

    Name of Committee: National Institute on Drug Abuse Special 
Emphasis Panel N44DA-9-2216-Web-Based Skills Training Agents (topic 
91).
    Date: May 5, 2009.
    Time: 12:30 p.m. to 1:30 p.m.
    Agenda: To review and evaluate contract proposals.
    Place: The Dupont Hotel, 1500 New Hampshire Avenue, NW., 
Washington, DC 20036.
    Contact Person: Nadine Rogers, Ph.D., Scientific Review 
Administrator, Office of Extramural Affairs, National Institute on 
Drug Abuse, NIH, DHHS, Room 220, MSC 8401, 6101 Executive Boulevard, 
Bethesda, MD 20892-8401. 301-402-2105. rogersn2@nida.nih.gov.

    This notice is being published less than 15 days prior to the 
meeting due to the timing limitations imposed by the review and 
funding cycle.

    Name of Committee: National Institute on Drug Abuse Special 
Emphasis Panel In Vitro Metabolism and Metabolite Quantification 
(09-8891).
    Date: May 19, 2009.
    Time: 9 a.m. to 2 p.m.
    Agenda: To review and evaluate contract proposals.
    Place: Courtyard by Marriott Rockville, 2500 Research Boulevard, 
Rockville, MD 20850.
    Contact Person: Lyle Furr, Contract Review Specialist, Office of 
Extramural Affairs, National Institute on Drug Abuse, NIH, DHHS, 
Room 220, MSC 8401, 6101 Executive Boulevard, Bethesda, MD 20892-
8401. (301) 435-1439. lf33c.nih.gov.

    Name of Committee: National Institute on Drug Abuse Special 
Emphasis Panel N01DA-9-2217: Data and Statistics Center for the CTN.
    Date: May 27-28, 2009.
    Time: 9:30 a.m. to 4 p.m.
    Agenda: To review and evaluate contract proposals.
    Place: Doubletree Bethesda Hotel, 8120 Wisconsin Avenue, 
Bethesda, MD 20814.
    Contact Person: Minna Liang, Ph.D., Scientific Review Officer, 
Training and Special Projects Review Branch, Office of Extramural 
Affairs, National Institute on Drug Abuse, NIH, 6101 Executive 
Blvd., Room 220, MSC 8401, Bethesda, MD 20852. 301-435-1432. 
liangm@nida.nih.gov.

    Name of Committee: National Institute on Drug Abuse Special 
Emphasis Panel Communication Support (09-1139).
    Date: May 28-29, 2009.
    Time: 9 a.m. to 1 p.m.
    Agenda: To review and evaluate contract proposals.
    Place: Courtyard by Marriott Rockville, 2500 Research Boulevard, 
Rockville, MD 20850.
    Contact Person: Lyle Furr, Contract Review Specialist, Office of 
Extramural Affairs, National Institute on Drug Abuse, NIH, DHHS, 
Room 220, MSC 8401, 6101 Executive Boulevard, Bethesda, MD 20892-
8401. (301) 435-1439. lf33c.nih.gov.

    Name of Committee: National Institute on Drug Abuse Special 
Emphasis Panel Drug Testing for Clinical Trials (09-8882).
    Date: June 3, 2009.
    Time: 9 a.m. to 1 p.m.
    Agenda: To review and evaluate contract proposals.
    Place: Courtyard by Marriott Rockville, 2500 Research Boulevard, 
Rockville, MD 20850.
    Contact Person: Lyle Furr, Contract Review Specialist, Office of 
Extramural Affairs, National Institute on Drug Abuse, NIH, DHHS, 
Room 220, MSC 8401, 6101 Executive Boulevard, Bethesda, MD 20892-
8401. (301) 435-1439. lf33c.nih.gov.

(Catalogue of Federal Domestic Assistance Program Nos 93279, Drug 
Abuse and Addiction Research Programs, National Institutes of 
Health, HHS)

    Dated: April 16, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. E9-9255 Filed 4-23-09; 8:45 am]
BILLING CODE 4140-01-M

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.